Psoriatic Arthritis

AB1135 CHARACTERIZING THE MINIMAL DISEASE ACTIVITY DOMAINS ACHIEVED BASED ON DIFFERENT TREATMENTS.
S. Scriffignano, F. M. Perrotta, M. Fatica, P. Triggianese, P. Conigliaro, M. Ferraioli, M. S. Chimenti, E. Lubrano

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1798; DOI: 10.1136/annrheumdis-2023-eular.2071
POS0024 RETENTION RATE OF TNF INHIBITORS (TNFI), ANTI-IL17, AND ANTI-IL12/23 DRUGS IN A SINGLE-CENTER COHORT OF PSORIATIC ARTHRITIS PATIENTS
M. Ferrito, G. Cincinelli, M. Manara, E. G. Favalli, R. Caporali

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 218; DOI: 10.1136/annrheumdis-2023-eular.3759
POS0347 DETERMINANTS OF PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN SPONDYLOARTHRITIS
C. Dantas Soares, S. Azevedo, F. Guimarães, H. Parente, M. Pontes-Ferreira, J. Tavares-Costa, D. Peixoto, C. Afonso, D. Santos-Faria

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 422-423; DOI: 10.1136/annrheumdis-2023-eular.6497
POS0782-PARE MANAGING PSORIATIC ARTHRITIS: PATIENTS’ VIEWS AND ATTITUDES TO USING AN ONLINE WELLNESS PROGRAM
W. B. Nowell, A. Degrassi, S. Venkatachalam, K. Gavigan, A. Krivohlavek, E. Rivera, M. E. Husni

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 683; DOI: 10.1136/annrheumdis-2023-eular.4080
POS1527 EFFECTS OF APREMILAST ON CHANGES IN CARDIOMETABOLIC PARAMETERS BY DIABETES AND OBESITY STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS
P. J. Mease, D. D. Gladman, I. B. Mcinnes, S. Cheng, S. Colgan, Y. Klyachkin, L. Teng, N. N. Mehta

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1125-1126; DOI: 10.1136/annrheumdis-2023-eular.45
POS1532 WHAT IS THE REAL IMPACT OF DEPRESSION ON CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS?
A. Martins, D. Santos Oliveira, R. Nicolau, T. Martins-Rocha, A. Bernardo, S. Pimenta, M. Bernardes, L. Costa

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1129; DOI: 10.1136/annrheumdis-2023-eular.1101
POS1536 ASSESSMENT OF PAIN OUTCOMES IN A PHASE 2 TRIAL OF DEUCRAVACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
P. J. Mease, L. Eder, A. Ogdie-Beatty, A. Deodhar, S. Banerjee, M. Nowak, J. Choi, T. Lehman, V. Strand

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1132-1133; DOI: 10.1136/annrheumdis-2023-eular.1691
POS1546 PATIENTS WITH PSORIATIC ARTHRITIS AT BIOLOGIC THERAPY SWITCH: THE COREVITAS PSORIASIS REGISTRY
P. J. Mease, E. Jones, A. Sima, S. Beaty, R. Low, B. Gomez, M. Gurrola, M. Lebwohl

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1142; DOI: 10.1136/annrheumdis-2023-eular.3988
POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS
A. Dotan, N. Ben-Shabat, D. Mcgonagle, H. Amital, A. Watad

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1148-1149; DOI: 10.1136/annrheumdis-2023-eular.4556
AB0090 IN VITRO EFFECTS OF METHOTREXATE, ANTI-PDE-4, AND ANTI-JAK TREATMENTS ON HEPATOCYTES STIMULATED BY PSORIATIC ARTHRITIS SERUM
I. Arias de la Rosa, L. Cuesta López, M. Ruiz-Ponce, M. D. López Montilla, C. López-Medina, C. Perez-Sanchez, M. D. Gahete, N. Herman-Sanchez, C. Lopez-Pedrera, A. Escudero Contreras, E. Collantes Estevez, N. Barbarroja Puerto

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1224; DOI: 10.1136/annrheumdis-2023-eular.3764

Main menu

Psoriatic Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriatic Arthritis

Pages